MOREPENLABPharmaceuticals
Morepen Laboratories Ltd — PE Ratio & Valuation Analysis
₹33.68
-2.22%
Current P/E31.50xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E35.7x11.7% below avg
✅
0.8% Discount to Industry
MOREPENLAB P/E 31.50x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹2.20 | ₹41 | 18.7x |
| 2024 | ₹1.88 | ₹78 | 41.6x |
| 2023 | ₹0.77 | ₹49 | 63.1x |
| 2022 | ₹1.96 | ₹38 | 19.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Morepen Laboratories Ltd Valuation
Morepen Laboratories Ltd (MOREPENLAB) currently trades at 31.50x earnings. The Pharmaceuticals sector average PE is 31.77x. MOREPENLAB is trading at a discount to peers — may indicate relative value. Historically, MOREPENLAB has traded at an average PE of 35.7x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.78%
Dividend Yield
0.46%
More on Morepen Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.